3672

    541540

    SOLARA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SOLARA ACTIVE PHA SCI LTD Share Price Today

    SOLARA ACTIVE PHA SCI LTD is currently trading at ₹575.2, down by ₹2.39 from the previous close. The stock touched an intraday high of ₹584.30 and a low of ₹571.00 during the latest trading session. Over the past one year, SOLARA ACTIVE PHA SCI LTD has delivered a loss of 8.4%, while the stock has declined 0.68% in the last one month.

    SOLARA ACTIVE PHA SCI LTD performance

    Today’s low Today’s high
    ₹ 571.00 ₹ 584.30
    ₹ 578.05
    52 week low 52 week high
    ₹ 422.00 ₹ 734.40
    ₹ 578.05
    Open Price ₹ 576.00
    Prev. Close ₹ 577.60
    Volume (Shares) 76119.00
    Total traded value ₹ 440.00
    Upper Circuit ₹ 693.10
    Lower Circuit ₹ 462.10
    info

    Investment Returns

    Over 1 Month -0.68% Over 3 Months 17.10% Over 6 Months 3.67% Over 1 Year -8.40%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SOLARA ACTIVE PHA SCI LTD fundamentals


    • Market cap (Cr) 2,762.20
    • P/E Ratio (TTM) -379.80
    • Beta 0.83
    • Book Value / share 263.41
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 9.73
    info icon alternate text
    • Market cap (Cr) 2,761.70
    • P/E Ratio (TTM) -379.80
    • Beta 0.74
    • Book Value / share 263.41
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 9.73
    info icon alternate text

    SOLARA ACTIVE PHA SCI LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 387.29
    Operating Expense 382.84
    Net Profit 9.73
    Net Profit Margin (%) 2.51
    Earnings Per Share (EPS) 2.23
    EBITDA 62.83
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 349.00
    Operating Expense 359.67
    Net Profit -17.42
    Net Profit Margin (%) -4.99
    Earnings Per Share (EPS) -3.97
    EBITDA 30.59
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 313.54
    Operating Expense 324.10
    Net Profit -10.08
    Net Profit Margin (%) -3.21
    Earnings Per Share (EPS) -2.36
    EBITDA 35.23
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 319.15
    Operating Expense 309.59
    Net Profit 10.53
    Net Profit Margin (%) 3.29
    Earnings Per Share (EPS) 2.46
    EBITDA 58.01
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 273.01
    Operating Expense 283.84
    Net Profit -4.88
    Net Profit Margin (%) -1.78
    Earnings Per Share (EPS) -1.65
    EBITDA 48.54
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 1368.98
    Operating Expense 1376.22
    Net Profit -7.24
    Net Profit Margin (%) -0.52
    Earnings Per Share (EPS) -1.64
    EBITDA 186.68
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 1283.76
    Operating Expense 1293.98
    Net Profit -1.08
    Net Profit Margin (%) -0.08
    Earnings Per Share (EPS) -0.27
    EBITDA 212.98
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 1288.92
    Operating Expense 1592.98
    Net Profit -566.87
    Net Profit Margin (%) -43.98
    Earnings Per Share (EPS) -157.48
    EBITDA -279.33
    Effective Tax Rate (%) -16.08
    Particulars MAR 2023 (Values in Cr)
    Revenue 1443.81
    Operating Expense 1510.73
    Net Profit -22.21
    Net Profit Margin (%) -1.53
    Earnings Per Share (EPS) -6.17
    EBITDA 156.18
    Effective Tax Rate (%) 50.40
    Particulars MAR 2022 (Values in Cr)
    Revenue 1268.34
    Operating Expense 1375.27
    Net Profit -58.56
    Net Profit Margin (%) -4.61
    Earnings Per Share (EPS) -16.29
    EBITDA 95.62
    Effective Tax Rate (%) 36.11
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 271.86
    ROE % 0.05
    ROCE % 5.41
    Total Debt to Total Equity 0.89
    EBITDA Margin 16.72
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 259.42
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.83
    EBITDA Margin -7.00
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 416.73
    ROE % -1.47
    ROCE % 1.74
    Total Debt to Total Equity 0.68
    EBITDA Margin 10.83
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 423.57
    ROE % -3.74
    ROCE % -0.65
    Total Debt to Total Equity 0.53
    EBITDA Margin 7.61
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 442.12
    ROE % 16.55
    ROCE % 14.72
    Total Debt to Total Equity 0.50
    EBITDA Margin 25.64
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 272.35
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.89
    EBITDA Margin 16.59
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 260.39
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.83
    EBITDA Margin -6.99
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 417.54
    ROE % -1.47
    ROCE % 1.74
    Total Debt to Total Equity 0.68
    EBITDA Margin 10.82
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 424.18
    ROE % -3.75
    ROCE % -0.67
    Total Debt to Total Equity 0.53
    EBITDA Margin 7.54
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 443.30
    ROE % 16.47
    ROCE % 14.66
    Total Debt to Total Equity 0.50
    EBITDA Margin 25.59
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.11
    Total Assets 2231.84
    Total Liabilities 2231.84
    Total Equity 1096.91
    Share Outstanding 4
    Price to Book Ratio 1.88
    Return on Assets (%) 0.02
    Return on Capital (%) 0.03
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 8.60
    Total Assets 2350.96
    Total Liabilities 2350.96
    Total Equity 936.58
    Share Outstanding 3
    Price to Book Ratio 1.43
    Return on Assets (%) -24.13
    Return on Capital (%) -29.31
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 8.89
    Total Assets 2899.28
    Total Liabilities 2899.28
    Total Equity 1502.45
    Share Outstanding 3
    Price to Book Ratio 0.79
    Return on Assets (%) -0.76
    Return on Capital (%) -0.89
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 47.25
    Total Assets 2944.96
    Total Liabilities 2944.96
    Total Equity 1527.18
    Share Outstanding 3
    Price to Book Ratio 1.57
    Return on Assets (%) -1.97
    Return on Capital (%) -2.28
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 198.54
    Total Assets 2613.58
    Total Liabilities 2613.58
    Total Equity 1592.77
    Share Outstanding 3
    Price to Book Ratio 3.15
    Return on Assets (%) 8.47
    Return on Capital (%) 10.07
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.97
    Total Assets 2225.10
    Total Liabilities 2225.10
    Total Equity 1096.21
    Share Outstanding 4
    Price to Book Ratio 1.88
    Return on Assets (%) -0.04
    Return on Capital (%) -0.06
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 8.48
    Total Assets 2346.60
    Total Liabilities 2346.60
    Total Equity 937.42
    Share Outstanding 3
    Price to Book Ratio 1.43
    Return on Assets (%) -24.15
    Return on Capital (%) -29.27
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 8.71
    Total Assets 2894.95
    Total Liabilities 2894.95
    Total Equity 1503.13
    Share Outstanding 3
    Price to Book Ratio 0.79
    Return on Assets (%) -0.76
    Return on Capital (%) -0.89
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 47.14
    Total Assets 2937.44
    Total Liabilities 2937.44
    Total Equity 1527.05
    Share Outstanding 3
    Price to Book Ratio 1.57
    Return on Assets (%) -1.99
    Return on Capital (%) -2.3
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 198.38
    Total Assets 2610.17
    Total Liabilities 2610.17
    Total Equity 1592.79
    Share Outstanding 3
    Price to Book Ratio 3.15
    Return on Assets (%) 8.46
    Return on Capital (%) 10.05
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.54
    Cash from Operations 213.72
    Cash from Investing -36.83
    Cash from Financing -180.48
    Net change in Cash -4.49
    Free Cash Flow 253.66
    Particulars MAR 2024 (Values in Cr)
    Net Income -488.42
    Cash from Operations 107.97
    Cash from Investing -3.51
    Cash from Financing -105.65
    Net change in Cash -0.29
    Free Cash Flow 149.03
    Particulars MAR 2023 (Values in Cr)
    Net Income -44.82
    Cash from Operations 142.71
    Cash from Investing -81.14
    Cash from Financing -112.76
    Net change in Cash -37.65
    Free Cash Flow 254.02
    Particulars MAR 2022 (Values in Cr)
    Net Income -91.10
    Cash from Operations -223.93
    Cash from Investing -242.85
    Cash from Financing 333.57
    Net change in Cash -151.31
    Free Cash Flow -15.31
    Particulars MAR 2021 (Values in Cr)
    Net Income 221.50
    Cash from Operations 188.82
    Cash from Investing -106.30
    Cash from Financing 92.49
    Net change in Cash 141.65
    Free Cash Flow 363.29
    Particulars MAR 2025 (Values in Cr)
    Net Income -1.08
    Cash from Operations 213.70
    Cash from Investing -36.83
    Cash from Financing -180.48
    Net change in Cash -4.51
    Free Cash Flow 253.64
    Particulars MAR 2024 (Values in Cr)
    Net Income -488.33
    Cash from Operations 110.03
    Cash from Investing -4.66
    Cash from Financing -106.52
    Net change in Cash -0.23
    Free Cash Flow 153.10
    Particulars MAR 2023 (Values in Cr)
    Net Income -44.78
    Cash from Operations 142.46
    Cash from Investing -81.13
    Cash from Financing -112.76
    Net change in Cash -37.72
    Free Cash Flow 253.77
    Particulars MAR 2022 (Values in Cr)
    Net Income -91.66
    Cash from Operations -223.72
    Cash from Investing -243.08
    Cash from Financing 333.59
    Net change in Cash -151.26
    Free Cash Flow -14.84
    Particulars MAR 2021 (Values in Cr)
    Net Income 220.96
    Cash from Operations 187.01
    Cash from Investing -105.25
    Cash from Financing 92.50
    Net change in Cash 141.69
    Free Cash Flow 360.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD. 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LTD. 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 521.10 56.34 4.78 5526.59 118.35 552.90

    SOLARA ACTIVE PHA SCI LTD shareholding pattern

    Holding
    42.89%
    41.99%
    11.33%
    3.77%
    36.57%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SOLARA ACTIVE PHA SCI LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    578.05 0.07 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 575.00
    • 26 Days 567.80
    • 10 Days 572.70
    • 50 Days 554.70
    • 12 Days 572.30
    • 100 Days 539.90
    • 20 Days 570.30
    • 200 Days 546.00
    568.88 PIVOT
    First Support 553.97 First Resistance 581.77 Second Support 541.08 Second Resistance 596.68 Third Support 526.17 Third Resistance 609.57
    RSI 52.14 ADX 29.95 MACD 4.61 Williams % R -59.89 Commodity Channel Index (CCI) -34.51
    Date 2026-07-10 Week 158380.00 Same Day 363229.00 Month 115819.00
    1 Year 0.80 3 Year 0.98
    Over 1 Month
    -0.68% down
    Over 1 Year
    -8.40% down
    Over 3 Months
    17.10% down
    Over 3 Years
    17.82% down
    Over 6 Months
    3.67% down
    Over 5 Years
    -17.97% down

    SOLARA ACTIVE PHA SCI LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Aug 2021 3.0 Final 20 Aug 2021 Equity shares
    19 Nov 2020 4.0 Interim 20 Nov 2020 Equity shares
    28 Jul 2020 2.0 Final 30 Jul 2020 Equity shares
    06 Aug 2019 5.0 Final 08 Aug 2019 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Aug 2021 3.0 Final 20 Aug 2021 Equity shares
    19 Nov 2020 4.0 Interim 20 Nov 2020 Equity shares
    28 Jul 2020 2.0 Final 30 Jul 2020 Equity shares
    06 Aug 2019 5.0 Final 08 Aug 2019 Equity shares

    Top Gainers

    Top Losers

    Solara Active Pharma Sciences Ltd share result highlights

    For Q1 of FY 25-26, the company's consolidated sales were ₹319 crore, and its net profit for the period stood at ₹11 crore. In the corresponding Q1 of FY 24-25, the sales were ₹363 crore with a net loss of ₹13 crore for the period.

    Date Source: screener.in, and corporate filings on NSE/BSE

    Solara Active Pharma Sciences Ltd share annual reports

    For FY 24-25, the company reported consolidated sales of ₹1,284 crore and a net profit of ₹1 crore. In the preceding year, FY 23-24, the company's sales were ₹1,289 crore with the net loss of ₹567 crore.

    Date Source: screener.in, and corporate filings on NSE/BSE

    Solara Active Pharma Sciences Ltd share dividend

    The company's stock has a face value of ₹10.0 per share and pays a dividend yield of 0.00%. The company has not declared any dividend in recent years. The last dividend of ₹3 was issued for FY 2021-22 with an ex-date of August 18, 2021.

    Date Source: screener.in, and corporate filings on NSE/BSE

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Solara Active Pharma Sciences Ltd?

    Answer Field

    Solara Active Pharma Sciences Ltd share price is for NSE ₹ 575.20 & for BSE ₹ 577.60 as on Jul 16 2026 03:29 PM.

    What is the Market Cap of Solara Active Pharma Sciences Ltd Share?

    Answer Field

    The market cap of Solara Active Pharma Sciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 16 2026 03:29 PM.

    What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd?

    Answer Field

    The 52 Week High and Low of Solara Active Pharma Sciences Ltd for NSE is ₹ 734.40 and ₹ 422.00 and for BSE is ₹ 734.20 and ₹ 422.85.

    What is 1 year return for Solara Active Pharma Sciences Ltd?

    Answer Field

    The 1 year returns on the stock has been -16.57%.

    What is the P/E Ratio of Solara Active Pharma Sciences Ltd Share?

    Answer Field

    As on Jul 16 2026 03:29 PM the price-to-earnings (PE) ratio for Solara Active Pharma Sciences Ltd share is -379.80.

    What is the PB ratio of Solara Active Pharma Sciences Ltd Share?

    Answer Field

    As on Jul 16 2026 03:29 PM, the price-to-book (PB) ratio for Solara Active Pharma Sciences Ltd share is 263.41.

    How to Buy Solara Active Pharma Sciences Ltd Share?

    Answer Field

    You can trade in Solara Active Pharma Sciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Solara Active Pharma Sciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Solara Active Pharma Sciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Solara Active Pharma Sciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    Who is the CEO of Solara Active Pharma Sciences Ltd?

    Answer Field

    The CEO of Solara Active Pharma Sciences Ltd is Poorvank Purohit, who also serves as the Managing Director of the company.

    When was Solara Active Pharma Sciences Ltd established?

    Answer Field

    Solara Active Pharma Sciences Ltd was incorporated on February 23, 2017. The company was formed from the demerger of the Active Pharmaceutical Ingredients (API) business from Strides Shasun Ltd.

    What factors influence the Solara Share Price?

    Answer Field

    The Solara share price is influenced by factors such as financial performance, market conditions, regulatory approvals, and the global demand for active pharmaceutical ingredients. Changes in debt levels, profit margins, and strategic moves like the sale of its stake in Sequent Penems also impact its share price.

    Is Solara Active Pharma Sciences Ltd debt-free?

    Answer Field

    No, Solara Active Pharma Sciences Ltd is not debt-free. As of March 2024, the company reported borrowings of Rs. 1,012 crores. However, it has been actively working to reduce its working capital requirements over time.

    What is the CAGR of Solara Share?

    Answer Field

    The Compound Annual Growth Rate (CAGR) of Solara’s stock price over the past five years stands at 13%. However, the three-year CAGR is negative at -7%, reflecting a decline in the stock’s value during that period.

    How has the Solara Share Price performed over the past year?

    Answer Field

    Over the past year, Solara’s share price has seen a significant increase, rising by 143%, demonstrating a positive market response despite challenges in revenue and profitability.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |